Related Experiment Video
Updated: May 4, 2026

Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing
Published on: October 18, 2013
Will we cure cancer by sequencing thousands of genomes?
1Virginia Tech, Department of Biological Sciences, 1981 Kraft Dr, Blacksburg, VA 24060, USA. jmn@vt.edu.
Abstract:
The promise to understand cancer and develop efficacious therapies by sequencing thousands of cancers has not occurred. Mutations in specific genes termed oncogenes and tumor suppressor genes are extremely heterogeneous amongst the same type of cancer as well as between cancers. They provide little selective advantage to the cancer and in functional tests have yet to be shown to be sufficient for transformation. Here I discuss the karyotyptic theory of cancer and ask if it is time for a new approach to understanding and ultimately treating cancer.
Insights
Sequencing thousands of cancers has not led to understanding or effective therapies. A new approach, like the karyotypic theory of cancer, may be needed for better cancer treatment.
Area of Science:
- Oncology
- Genetics
- Cancer Biology
Background:
- Despite extensive cancer genome sequencing, a comprehensive understanding of cancer development and effective therapies remains elusive.
- Genetic mutations in oncogenes and tumor suppressor genes show significant heterogeneity and often lack sufficient selective advantage or transformative capacity.
Discussion:
- The current focus on gene mutations may not fully capture the complexity of cancer initiation and progression.
- The karyotypic theory of cancer, which emphasizes chromosomal abnormalities, offers an alternative framework for understanding tumorigenesis.
Key Insights:
- Cancer's complexity may stem from factors beyond simple gene mutations, such as large-scale chromosomal alterations.
- The heterogeneity of mutations within cancers suggests that a single-driver mutation model is insufficient.
Outlook:
- Re-evaluating established cancer theories and exploring alternative models like the karyotypic theory is crucial.
- A paradigm shift in cancer research is necessary to develop more efficacious diagnostic and therapeutic strategies.
More Related Videos
13:24Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
Published on: April 11, 2016
11:15Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
Published on: September 20, 2016
Related Concept Videos
Genomics
Next-generation Sequencing
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
Sanger Sequencing
Maxam-Gilbert Sequencing
Challenges of the Maxam-Gilbert Method
The...
RNA-seq
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while...
Evolutionary Relationships through Genome Comparisons